Changes in Colorectal Cancer Screening Modalities Among Insured Individuals

Did use of colorectal cancer (CRC) screening modalities change in the US between 2017 and 2024?In this cohort study of 24 973 642 privately insured individuals aged 50 to 75 years, the use of colonoscopy and fecal immunochemical test decreased, and stool DNA test use increased. Males had higher use of colonoscopy while females had higher use of stool DNA test; areas with high socioeconomic status (SES) and metropolitan areas had more frequent use of both modalities.These findings suggest that use of different CRC screening modalities changed, varying by sex, area-level SES, and urban or rural residence.

Corresponding Author: Sunny Siddique, MD, PhD, Department of Chronic Disease Epidemiology, Yale School of Public Health, 60 College St, New Haven, CT 06510 (sunny.siddique@yale.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.